These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 17508000

  • 1. Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model.
    Hayun M, Okun E, Hayun R, Gafter U, Albeck M, Longo DL, Sredni B.
    Leukemia; 2007 Jul; 21(7):1504-13. PubMed ID: 17508000
    [Abstract] [Full Text] [Related]

  • 2. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S.
    Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
    [Abstract] [Full Text] [Related]

  • 3. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
    Vrana JA, Rao AS, Wang Z, Jarvis WD, Grant S.
    Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
    [Abstract] [Full Text] [Related]

  • 4. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
    Kalechman Y, Albeck M, Sredni B.
    Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
    [Abstract] [Full Text] [Related]

  • 5. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
    Sredni B, Kalechman Y, Albeck M, Gross O, Aurbach D, Sharon P, Sehgal SN, Gurwith MJ, Michlin H.
    Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
    [Abstract] [Full Text] [Related]

  • 6. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S.
    Exp Cell Res; 1998 Oct 10; 244(1):105-16. PubMed ID: 9770354
    [Abstract] [Full Text] [Related]

  • 7. Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways.
    Kalechman Y, Longo DL, Catane R, Shani A, Albeck M, Sredni B.
    Int J Cancer; 2000 Apr 15; 86(2):281-8. PubMed ID: 10738258
    [Abstract] [Full Text] [Related]

  • 8. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA, Saunders AM, Chellappan SP, Grant S.
    Differentiation; 1998 May 15; 63(1):33-42. PubMed ID: 9615391
    [Abstract] [Full Text] [Related]

  • 9. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S.
    Biochem Pharmacol; 1994 Mar 02; 47(5):839-52. PubMed ID: 8135859
    [Abstract] [Full Text] [Related]

  • 10. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD.
    Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972
    [Abstract] [Full Text] [Related]

  • 11. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
    Sredni B, Gal R, Cohen IJ, Dazard JE, Givol D, Gafter U, Motro B, Eliyahu S, Albeck M, Lander HM, Kalechman Y.
    FASEB J; 2004 Feb 10; 18(2):400-2. PubMed ID: 14656992
    [Abstract] [Full Text] [Related]

  • 12. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S, Wang Z, Grant S.
    Mol Pharmacol; 2003 Jan 10; 63(1):232-42. PubMed ID: 12488556
    [Abstract] [Full Text] [Related]

  • 13. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).
    Wang S, Guo CY, Castillo A, Dent P, Grant S.
    Biochem Pharmacol; 1998 Sep 01; 56(5):635-44. PubMed ID: 9783732
    [Abstract] [Full Text] [Related]

  • 14. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM.
    Mol Pharmacol; 1994 Nov 01; 46(5):840-50. PubMed ID: 7969070
    [Abstract] [Full Text] [Related]

  • 15. Bryostatin-1 and 1alpha,25-dihydroxyvitamin D3 synergistically stimulate the differentiation of NB4 acute promyelocytic leukemia cells.
    Song XD, Norman AW.
    Leukemia; 1999 Feb 01; 13(2):275-81. PubMed ID: 10025902
    [Abstract] [Full Text] [Related]

  • 16. Synergism between AS101 and PMA in lymphokine production.
    Sredni B, Kalechman Y, Shalit F, Albeck M.
    Immunology; 1990 Jan 01; 69(1):110-6. PubMed ID: 2107143
    [Abstract] [Full Text] [Related]

  • 17. Induction therapy in a multiple myeloma mouse model using a combination of AS101 and melphalan, and the activity of AS101 in a tumor microenvironment model.
    Hayun M, Saida H, Albeck M, Peled A, Haran-Ghera N, Sredni B.
    Exp Hematol; 2009 May 01; 37(5):593-603. PubMed ID: 19375650
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J, Freemerman AJ, Wu-Pong S, Jarvis WD, Grant S.
    Biochem Pharmacol; 1997 Sep 01; 54(5):563-73. PubMed ID: 9337072
    [Abstract] [Full Text] [Related]

  • 19. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
    Kraft AS, Smith JB, Berkow RL.
    Proc Natl Acad Sci U S A; 1986 Mar 01; 83(5):1334-8. PubMed ID: 3456591
    [Abstract] [Full Text] [Related]

  • 20. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C.
    Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.